BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu F, Dahlhamer JM, Zammitti EP, Wheaton AG, Croft JB. Health-Risk Behaviors and Chronic Conditions Among Adults with Inflammatory Bowel Disease - United States, 2015 and 2016. MMWR Morb Mortal Wkly Rep. 2018;67:190-195. [PMID: 29447146 DOI: 10.15585/mmwr.mm6706a4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Rodriguez DM, Hintze KJ, Rompato G, Wettere AJV, Ward RE, Phatak S, Neal C, Armbrust T, Stewart EC, Thomas AJ, Benninghoff AD. Dietary Supplementation with Black Raspberries Altered the Gut Microbiome Composition in a Mouse Model of Colitis-Associated Colorectal Cancer, although with Differing Effects for a Healthy versus a Western Basal Diet. Nutrients 2022;14. [PMID: 36558431 DOI: 10.3390/nu14245270] [Reference Citation Analysis]
2 Garcia C, Anto L, Blesso CN. Effects of Milk Polar Lipids on DSS-Induced Colitis Severity Are Dependent on Dietary Fat Content. Nutrients 2022;14. [PMID: 36501176 DOI: 10.3390/nu14235145] [Reference Citation Analysis]
3 Aswani-Omprakash T, Shah ND. Sociocultural Considerations for Food-Related Quality of Life in Inflammatory Bowel Disease. Gastroenterol Clin North Am 2022;51:885-95. [PMID: 36376002 DOI: 10.1016/j.gtc.2022.07.013] [Reference Citation Analysis]
4 Meyer A, Neumann A, Drouin J, Weill A, Carbonnel F, Dray-Spira R. Benefits and Risks Associated With Continuation of Anti-Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease : A Nationwide Emulation Trial. Ann Intern Med 2022. [PMID: 36162111 DOI: 10.7326/M22-0819] [Reference Citation Analysis]
5 Alrubia S, Mao J, Chen Y, Barber J, Rostami-Hodjegan A. Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs. Clin Pharmacokinet 2022. [PMID: 36056298 DOI: 10.1007/s40262-022-01169-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Xu F, Carlson SA, Liu Y, Greenlund KJ. Urban-Rural Differences in Health Care Utilization for Inflammatory Bowel Disease in the USA, 2017. Dig Dis Sci 2022;67:3601-11. [PMID: 34633623 DOI: 10.1007/s10620-021-07264-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hirsch RD, Keung C, Con D, Vasudevan A, Van Langenberg DR, Niewiadomski O. Direct health care costs of managing perianal Crohn's Disease in a population based cohort. Scand J Gastroenterol 2022;57:432-8. [PMID: 34932436 DOI: 10.1080/00365521.2021.2016944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Xu F, Wheaton AG, Liu Y, Greenlund KJ. Major ambulatory surgery among US adults with inflammatory bowel disease, 2017. PLoS ONE 2022;17:e0264372. [DOI: 10.1371/journal.pone.0264372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Naegeli AN, Balkaran BL, Shan M, Hunter TM, Lee LK, Jairath V. The impact of symptom severity on the humanistic and economic burden of inflammatory bowel disease: a real-world data linkage study. Curr Med Res Opin 2022;:1-26. [PMID: 35175166 DOI: 10.1080/03007995.2022.2043655] [Reference Citation Analysis]
10 Brunt H, Chapman JC. The Inflammatory Bowel Disease-Focused Primary Care Provider: An Addition to the IBD Specialty Medical Home. Am J Gastroenterol 2022;117:209-12. [PMID: 34797222 DOI: 10.14309/ajg.0000000000001569] [Reference Citation Analysis]
11 Li J, Hou W, Lin S, Wang L, Pan C, Wu F, Liu J. Polydopamine Nanoparticle-Mediated Dopaminergic Immunoregulation in Colitis. Adv Sci (Weinh) 2022;9:e2104006. [PMID: 34713621 DOI: 10.1002/advs.202104006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Gagnon É, Mitchell PL, Manikpurage H, Abner E, Taba N, Esko T, Ghodsian N, Thériault S, Mathieu P, Arsenault BJ. A multidimensional Mendelian randomization study on the impact of gut dysbiosis on chronic diseases and human longevity.. [DOI: 10.1101/2021.08.20.21262026] [Reference Citation Analysis]
13 Hyun CK. Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:9139. [PMID: 34502047 DOI: 10.3390/ijms22179139] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
14 Xu F, Carlson SA, Liu Y, Greenlund KJ. Prevalence of Inflammatory Bowel Disease Among Medicare Fee-For-Service Beneficiaries - United States, 2001-2018. MMWR Morb Mortal Wkly Rep 2021;70:698-701. [PMID: 33983913 DOI: 10.15585/mmwr.mm7019a2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
15 Suls J, Bayliss EA, Berry J, Bierman AS, Chrischilles EA, Farhat T, Fortin M, Koroukian SM, Quinones A, Silber JH, Ward BW, Wei M, Young-Hyman D, Klabunde CN. Measuring Multimorbidity: Selecting the Right Instrument for the Purpose and the Data Source. Med Care 2021;59:743-56. [PMID: 33974576 DOI: 10.1097/MLR.0000000000001566] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
16 Xu F, Carlson SA, Wheaton AG, Greenlund KJ. COVID-19 Hospitalizations Among U.S. Medicare Beneficiaries With Inflammatory Bowel Disease, April 1 to July 31, 2020. Inflamm Bowel Dis 2021;27:1166-9. [PMID: 33904584 DOI: 10.1093/ibd/izab041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Shakespear-Druery J, De Cocker K, Biddle SJH, Gavilán-Carrera B, Segura-Jiménez V, Bennie J. Assessment of muscle-strengthening exercise in public health surveillance for adults: A systematic review. Prev Med 2021;148:106566. [PMID: 33878352 DOI: 10.1016/j.ypmed.2021.106566] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
18 Voyvodic LC, Khan NZ, Lam AW, Horn AR, Mont MA, Razi AE. Crohn's Disease is Associated with Longer In-Hospital Lengths of Stay and Higher Rates of Complications and Costs after Primary Total Hip Arthroplasty. J Arthroplasty 2021;36:2110-5. [PMID: 33637381 DOI: 10.1016/j.arth.2021.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 da Rocha GHO, de Paula-Silva M, Broering MF, Scharf PRDS, Matsuyama LSAS, Maria-Engler SS, Farsky SHP. Pioglitazone-Mediated Attenuation of Experimental Colitis Relies on Cleaving of Annexin A1 Released by Macrophages. Front Pharmacol 2020;11:591561. [PMID: 33519451 DOI: 10.3389/fphar.2020.591561] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Lee HS, Lobbestael E, Vermeire S, Sabino J, Cleynen I. Inflammatory bowel disease and Parkinson's disease: common pathophysiological links. Gut 2021;70:408-17. [PMID: 33067333 DOI: 10.1136/gutjnl-2020-322429] [Cited by in Crossref: 30] [Cited by in F6Publishing: 40] [Article Influence: 15.0] [Reference Citation Analysis]
21 Caldera F, Mercer M, Samson SI, Pitt JM, Hayney MS. Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity. Vaccine 2021;39 Suppl 1:A15-23. [PMID: 33422377 DOI: 10.1016/j.vaccine.2020.11.037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
22 Kamp KJ, Stommel M. Health-Related Quality of Life Among Patients With Inflammatory Bowel Disease: A Case Control Study. Gastroenterol Nurs 2021;44:21-30. [PMID: 33351519 DOI: 10.1097/SGA.0000000000000491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Xu F, Liu Y, Wheaton AG, Rabarison KM, Croft JB. Trends and Factors Associated with Hospitalization Costs for Inflammatory Bowel Disease in the United States. Appl Health Econ Health Policy 2019;17:77-91. [PMID: 30259396 DOI: 10.1007/s40258-018-0432-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
24 Han MK, Anderson R, Viennois E, Merlin D. Examination of food consumption in United States adults and the prevalence of inflammatory bowel disease using National Health Interview Survey 2015. PLoS One 2020;15:e0232157. [PMID: 32324818 DOI: 10.1371/journal.pone.0232157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
25 Vincent G, Novak EA, Siow VS, Cunningham KE, Griffith BD, Comerford TE, Mentrup HL, Stolz DB, Loughran P, Ranganathan S, Mollen KP. Nix-Mediated Mitophagy Modulates Mitochondrial Damage During Intestinal Inflammation. Antioxid Redox Signal 2020;33:1-19. [PMID: 32103677 DOI: 10.1089/ars.2018.7702] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
26 Ye Y, Manne S, Treem WR, Bennett D. Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016. Inflamm Bowel Dis 2020;26:619-25. [PMID: 31504515 DOI: 10.1093/ibd/izz182] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
27 Rubio MG, Amo-Mensah K, Gray JM, Nguyen VQ, Nakat S, Grider D, Love K, Boone JH, Sorrentino D. Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease. World J Gastrointest Pathophysiol 2019; 10(5): 54-63 [PMID: 31911845 DOI: 10.4291/wjgp.v10.i5.54] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
28 Xu F, Dahlhamer JM, Terlizzi EP, Wheaton AG, Croft JB. Receipt of Preventive Care Services Among US Adults with Inflammatory Bowel Disease, 2015-2016. Dig Dis Sci 2019;64:1798-808. [PMID: 30746631 DOI: 10.1007/s10620-019-05494-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
29 Lee HS, Cleynen I. Molecular Profiling of Inflammatory Bowel Disease: Is It Ready for Use in Clinical Decision-Making? Cells. 2019;8. [PMID: 31167397 DOI: 10.3390/cells8060535] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
30 Kang EA, Han K, Chun J, Soh H, Park S, Im JP, Kim JS. Increased Risk of Diabetes in Inflammatory Bowel Disease Patients: A Nationwide Population-based Study in Korea. J Clin Med. 2019;8. [PMID: 30862129 DOI: 10.3390/jcm8030343] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 9.3] [Reference Citation Analysis]
31 Langgartner D, Lowry CA, Reber SO. Old Friends, immunoregulation, and stress resilience. Pflugers Arch 2019;471:237-69. [PMID: 30386921 DOI: 10.1007/s00424-018-2228-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]